836 4. McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 1990;25(3):267–70. 5. Ter Haar G, Sinnett D, Rivens I. High intensity focused ultrasound–a surgical technique for the treatment of discrete liver tumours. Phys Med Biol. 1989;34(11):1743–50. 6. Tian JH, Xu BX, Zhang JM, Dong BW, Liang P, Wang XD. Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. J Nucl Med. 1996;37(6):958–63. 7. Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol. 2007;25(8):978–86. 8. Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, Lam MG, et al. Yttrium-90 microsphere radio- embolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol. 2009;19:951–9. 9. Lewandowski RJ, Geschwind JF, Liapi E, Salem R. Transcatheter intraarterial therapies: rationale and overview. Radiology. 2011;259(3):641–57. 10. Kim JK, Han KH, Lee JT, Paik YH, Ahn SH, Lee JD, et al. Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma. Clin Cancer Res. 2006;12(2):543–8. 11. Seevinck PR, Seppenwoolde JH, de Wit TC, Nijsen JF, Beekman FJ, van het Schip AD, et al. Factors affecting the sensitivity and detection limits of MRI, CT, and SPECT for multimodal diagnostic and therapeutic agents. Anticancer Agents Med Chem. 2007;7:317–34. 12. Bult W, Seevinck PR, Krijger GC, Visser T, Kroon-Batenburg LM, Bakker CJ, et al. Microspheres with ultrahigh holmium content for radioablation of malignancies. Pharm Res. 2009;26(6):1371–8. 13. Bult W, Kroeze SGC, Elschot M, Seevinck PR, Beekman FJ, Luijten PR, Hennink WE, van het Schip AD, Bosch JLHR, Nijsen JFW, Jans JJM. Intratumoral administration of holmium-166 acetylacetonate microspheres as a novel minimally-invasive treatment for small kidney tumors. Thesis Utrecht University, 2010. p. 89–105. 14. Bult W, Vente MAD, Vandermeulen E, Gielen I, Seevinck PR, Saunders J, van het Schip AD, Bakker CJG, Krijger GC, Peremans K, Nijsen JFW. Interstitial microbrachytherapy using holmium-166 acetylacetonate microspheres: a pilot study in feline liver cancer patients. Brachytherapy, accepted for publication 15. Vente MA, Nijsen JF, de Roos R, van Steenbergen MJ, Kaaijk CN, Koster-Ammerlaan MJ, et al. Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radio-embolization: a validation study. Biomed Microdevices. 2009;11(4):763–72. 16. Zielhuis SW, Nijsen JFW, Krijger GC, van het Schip AD, Hennink WE. Holmium-loaded poly(L-lactic acid) microspheres: In vitro degradation study. Biomacromolecules. 2006;7(7):2217–23. 17. Chughtai K, Heeren RM. Mass spectrometric imaging for biomedical tissue analysis. Chem Rev. 2010;110(5):3237–77. Bult et al. 18. van Es RJ, Franssen O, Dullens HF, Bernsen MR, Bosman F, Hennink WE, et al. The VX2 carcinoma in the rabbit auricle as an experimental model for intra-arterial embolization of head and neck squamous cell carcinoma with dextran microspheres. Lab Anim. 1999;33(2):175–84. 19. Nijsen JFW. Radioactive holmium poly(L-lactic acid) microspheres for treatment of hepatic malignancies: efficacy in rabbits. Thesis Utrecht University, 2001. p. 109–122. 20. Smits ML, Nijsen JF, van den Bosch MA, Lam MG, Vente MA, Huijbregts JE, et al. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial. J Exp Clin Cancer Res. 2010;29:70. 21. Bult W, Varkevisser R, Soulimani F, Seevinck PR, de Leeuw H, Bakker CJ, et al. Holmium nanoparticles: preparation and in vitro characterization of a new device for radioablation of solid malignancies. Pharm Res. 2010;27(10):2205–12. 22. Lide DR, ed. CRC handbook of chemistry and physics, 89th Edition (Internet Version 2009). Boca Raton, FL: CRC Press/Taylor and Francis. 23. Dong X, Gusev A, Hercules DM. Characterization of poly- siloxanes with different functional groups by time-of-flight secondary ion mass spectrometry. J Am Soc Mass Spectrom. 1998;9(4):292–8. 24. Kijkowska R, LeGeros RZ. Preparation and properties of lanthanide phosphates. Key Eng Mater. 2005;246/248(1/2): 79–82. 25. Rouxel J, Tournoux M. Chimie douce with solid precursors, past and present. Solid State Ionics. 1996;84(3–4):141–9. 26. Lu C, Ding ZF, Lipson RH. A new chimie douce approach to crystalline vanadium pentoxide nanobelts. J Mater Chem. 2009;19(36):6512–5. 27. Harlan CJ, Kareiva A, MacQueen DB, Cook R, Barron AR. Yttrium-doped alumoxanes: A chimie douce route to Y3Al5O12 (YAG) and Y4Al2O9 (YAM). Adv Mater. 1997;9(1):68–71. 28. Suzuki YS, Momose Y, Higashi N, Shigematsu A, Park KB, Kim YM, et al. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice. J Nucl Med. 1998;39 (12):2161–6. 29. Sinton TJ, Cowley DM, Bryant SJ. Reference intervals for calcium, phosphate, and alkaline phosphatase as derived on the basis of multichannel-analyzer profiles. Clin Chem. 1986;32(1 Pt 1):76–9. 30. Vente MAD, Nijsen JFW, de Wit TC, Seppenwoolde JH, Krijger GC, Seevinck PR, et al. Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L: -lactic acid) microspheres in healthy pigs. Eur J Nucl Med Mol Imaging. 2008;35(7):1259–71. 31. Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol. 2002;13(9 Pt 2):S223–9. 32. Durbin PW. Metabolic characteristics within a chemical family. Health Phys. 1960;2:225–38.